India’s ReNew Power to list on Nasdaq following US$8bn deal with US SPAC Email
ReNew Power has a portfolio of more than 100 operational utility-scale PV and wind projects in India. Image: ReNew Power via Twitter.
Independent power producer ReNew Power has agreed to go public through a merger with RMG Acquisition Corporation II, a US special purpose acquisition company (SPAC), in a deal that values the combined entity at US$8 billion.
India-based ReNew said the transaction will bolster its position in solar and wind generation in its home market by funding medium-term growth opportunities, as well as paying down debt.
ReNew Power likely to explore India listing: CEO
ReNew Power Ventures chairman and managing director Sumant Sinha said the firm is looking at different alternatives to raise capital
(Mint)
Share Via
Read Full Story
ReNew Power Ventures Pvt. Ltd may explore an India listing, chairman and managing director Sumant Sinha said in an interview.
The development comes in the backdrop of the Goldman Sachs-backed clean energy company announcing a merger with Nasdaq-listed special purpose acquisition company (SPAC) RMG Acquisition Corp. II (RMG II) on Wednesday, at an enterprise value of around $8 billion. The new entity, ReNew Energy Global Plc, will be listed on the Nasdaq under the ticker symbol ‘RNW’, at an equity value of $4.4 billion. In response to a query on considering an India listing plan, Sinha said: “We definitely might.
India s ReNew Power to merge with blank cheque firm RMG II in $8bn deal nsenergybusiness.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from nsenergybusiness.com Daily Mail and Mail on Sunday newspapers.
Coronil controversy: IMA asks Patanjali to furnish documents
Coronil Tablet launched by Patanjali
1 min read
. Updated: 25 Feb 2021, 11:42 PM IST ANI
The tussle between Patanjali and Indian Medical Association (IMA) has intensified over the former sCoronil Ayurvedic medicine with IMA on Thursday accepting the open challenge by the company s Managing Director Acharaya Balkrishna.
Share Via
Read Full Story
The tussle between Patanjali and Indian Medical Association (IMA) has intensified over the former s Coronil Ayurvedic medicine with IMA on Thursday accepting the open challenge by the company s Managing Director Acharaya Balkrishna.
Speaking to ANI, Dr Jayesh Lele, Secretary-General of IMA said: We accept the challenge and have already demanded the very transparency, clarity and whatever certification they have received from World Health Organization (WHO) and DGCI, process and protocols followed for bringing out this type of medicine.
Cyril Amarchand Mangaldas advises ReNew Power laosnews.net - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from laosnews.net Daily Mail and Mail on Sunday newspapers.